Boston Scientific announces its new generation PFA product---FARAWAVE NAVReceived CE approval for marketing, applicable for the treatment of paroxysmal atrial fibrillation (AF).
“FARAVIEThe combination of W software and FARAWAVE NAV ablation catheter for doctors"This is an important milestone. The combination of these technologies' navigation and visualization capabilities can improve guidance, reduce fluoroscopy time, and enable accurate assessment of energy delivery during pulmonary vein isolation procedures. With high-quality mapping and optimized workflows, we can enhance the effectiveness of interventions and deliver better outcomes for patients."---Garcia Bolao Clínica Universidad de Navarra"By integrating innovative mapping technology into a single catheter,FARAPULSEPFA has revolutionized the treatment of atrial fibrillation and set a new benchmark for clinical innovation and therapeutic care. Specifically designed forFARAPULSE PFAThe designed Farawave Nav ablation catheter and Faraview software provide a complete and effective solution for atrial fibrillation mapping and ablation, improving the efficiency and accuracy of the procedure.---Caroline Bravo, Vice President of Rhythm Management, Boston Scientific EMEAFARAWAVE NAVThe emergence makes the entire ablation process simpler, more precise, and allows doctors to reduce radiation exposure. Supporting...FARAVIEW software provides doctors with an intuitive mapping process, such as dynamic views of catheter placement, shape, and rotation, offering greater peace of mind during ablation procedures.
October last yearFARAVIEW Software andFARAWAVE NAVThe ablation catheter has been approved by the FDA for marketing, becoming the first PFA ablation catheter with mapping functionality to be approved by the FDA. With this CE approval, Boston Scientific has become the second company, after Medtronic, to launch a PFA product with mapping functionality in Europe.
Currently, Boston Scientific and Medtronic are the two most promising companies in the electrophysiology field. Market forecasts predict that either Boston Scientific or Medtronic will become the leader in this field. However, Boston Scientific is currently slightly ahead of Medtronic. Boston Scientific was the first to reach $1 billion in sales (within a year) for a product during the PFA era, a feat that neither Medtronic nor Johnson & Johnson has yet achieved.
With mapping functionFARAWAVE NAVThe launch in Europe put Boston Scientific and Medtronic back on the same starting line. The two will engage in a new round of competition in the European and North American markets, making it difficult to determine a winner in the short term. However, the fierce battle between Boston Scientific and Medtronic will hurtPossiblyStrongLifeAndAbbott。
FARAWAVE NAVIt is an upgrade of the previous generation PFA product, FARAPULSE. It looks very similar to the FARAPULSE ablation catheter (FARAWAVE) in appearance but features magnetic navigation, which the previous generation lacked, and is equipped with a dedicated 3D FARAVIEW module (software). This enables FARAWAVE NAV to have both ablation and mapping functions, making PFA ablation more precise, reducing fluoroscopy time, and helping doctors evaluate the location of energy delivery, with the aim of further improving patient outcomes.
Compared toFARAPULSE'sFARAWAVE NAV Advantages- Ablation Requires Only One Catheter
With the help of the magnetic tracking FARAWAVE NAV pulsed field ablation catheter, doctors can collect geometry, perform ablations, and confirm workflows, thereby avoiding the need for additional mapping catheters or extra catheter exchanges.FAThe RAWAVE NAV ablation catheter can complete left atrial ablation;- Dynamic Shape Visualization
FARAVIEW is specifically designed for the unique shape of the FARAWAVE NAV catheter, providing valuable insights to physicians for evaluating ablation catheters.Shape, Positioning, and Rotation, which may potentially reduce the use of fluorescence during surgery.FARAVIEW is equipped with an innovative tagging tool that enables doctors to intuitively visualize PFA delivery, allowing them to plan, execute, and confirm ablations to support efficient procedures.
FARAWAVE NAVDemonstration
Boston Scientific commits to innovation for life. It is dedicated to innovative medical solutions, improving the lives of patients worldwide. For over four decades, Boston Scientific has consistently led the global medical technology industry by providing a wide range of high-performance medical solutions, addressing critical treatment needs for many patients and reducing healthcare costs.
